Clinical trial
Combretastatin A4 Phosphate in Treating Patients With Advanced Anaplastic…
NCT00060242 · Case Comprehensive Cancer Center, Other · Completed
Key facts
| NCT number | NCT00060242 |
|---|---|
| Title | Combretastatin A4 Phosphate in Treating Patients With Advanced Anaplastic Thyroid Cancer |
| Official title | Phase II Trial Of Combretastatin A-4 Phosphate (CA4P) In Advanced Anaplastic Carcinoma Of The Thyroid |
| Lead sponsor | Case Comprehensive Cancer Center, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Head and Neck Cancer |
| Intervention type | Drug |
| Interventions | fosbretabulin disodium |
| Enrollment | 26 |
| Start date | Feb 1, 2003 |
| Primary completion | Feb 1, 2007 |
| Completion | Jan 1, 2008 |
| First posted | May 7, 2003 |
| Last update posted | Jun 11, 2010 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: